All posts by imreal

Conga® Achieves ISO 27001 and 27701 Certifications


Conga®, the leader in end-to-end Digital Document Transformation (DDX), today announced that it has completed its annual audit examinations and obtained certification to new standards. Conga’s annual compliance program now includes assessment reports and certifications covering HIPAA, ISO 27001, ISO 27701, SOC 1 Type 2, and SOC 2 Type 2. These assurance activities, performed by Coalfire Controls, LLC, reinforce Conga’s unwavering commitment to building and maintaining partnerships with its customers built on transparency and assurance.

Conga is committed to prioritizing and understanding the serious challenges that organizations face when it comes to security, privacy and compliance. The company has designed an approach to compliance that includes regulations and industry-recognized certifications, including the latest ISO 27701 standards, as well as offering a trust and assurance portal that is unmatched by its peers. This helps increase Conga’s customers confidence that their data is safe and secure while supporting their compliance throughout the entire document process.

“In an evolving risk landscape comprised of diverse threat factors, service organizations are being challenged with the continuous improvement of their baseline security posture. Conga has adopted the perspective of ‘first mover’ backed by their achievements towards multiple information security, privacy, and governance reports and certifications,” said David Forman, managing principal, ISO Assurance at Coalfire. “This combination of third-party assurance has largely been avoided by industry peers due to the upfront commitment, required in-house expertise and costs. Conga routinely demonstrates a culture of security and privacy within all areas of its operations that is artificially creating a new benchmark for the sector in response to increased regulation.”

Added Mary Sparks, vice president of privacy and compliance at Conga, “We understand the critical importance of the data our more than 11,000 customers — often across highly-regulated industries — entrust to us. As a trusted partner, it is our duty to build the latest requirements and regulations into every single thing we do. The achievement of these certifications and audit reports provides independent verification that our privacy, security, availability and confidentiality controls are tested and operated in strict adherence to the highest possible standards.”

For more information on Conga’s security practices, visit https://conga.com/security-data-sheets

About Conga

Conga continually sets the standard for Digital Document Transformation (DDX). The Conga DDX Suite helps 11,000+ organizations in 85 countries including AWS, GE, Hilton Worldwide and Salesforce transform day-to-day business by creating, managing and unleashing the power of the everyday documents. The company is privately-held and based in Broomfield, Colo. with global operations across North America, Europe and Australia. Learn more at http://www.conga.com or follow Conga on Twitter: @getconga.

Share article on social media or email:

BayMark Expands Opioid Addiction Treatment Services In Ohio


“We are pleased to be expanding access into Northern Ohio. MedMark offers unrivaled care for those struggling with opioid addiction, and will continue that practice as we welcome patients in our newest facility.” – Frank Baumann, Chief Operating Officer.

BayMark Health Services has announced the opening of MedMark Treatment Centers Kent, expanding access to opioid addiction treatment services into northern Ohio. Conveniently located at 2500 State Route 59, 30 minutes outside of Akron, MedMark Kent is accepting new patients and has safety precautions in place to do so with our patient’s health top of mind as we address both the coronavirus pandemic and the opioid epidemic.

MedMark Kent will provide medically-supervised, medication-assisted treatment (MAT), administering methadone or buprenorphine, counseling and support services for those seeking treatment for opioid use disorder. As essential medical facilities, MedMark Treatment Centers are accepting new patients and following all CDC guidelines for social distancing and sanitizing throughout the facility.

“Ohio is currently experiencing the impact of two significant public health emergencies,” commented David K. White, Ph.D., CEO of BayMark Health Services. “The opioid epidemic has hit Ohio incredibly hard, and a significant amount of loss has been experienced throughout the state over many years. Now the coronavirus pandemic is impacting all citizens and intensifying that loss. We proceeded with the opening of our new location in Kent to ensure that as many people as possible have access to opioid treatment, both during this stressful and uncertain time, as well as once the coronavirus has passed.”

MedMark Treatment Centers are known across the country as providers of comprehensive, individualized treatment for opioid use disorder. Through medication management and counseling, MAT reduces the symptoms of withdrawal and cravings, paving the way for patients to focus on addressing the causes and consequences of their addiction and supporting them to regain stability in their lives. Additionally, MedMark Kent will provide addiction education, relapse prevention, lab testing, coordinated care for pregnant women and linkages to community resources to assist patients on their path to recovery.

Chief Operating Officer Frank Baumann added, “We are pleased to be expanding access into Northern Ohio. MedMark offers unrivaled care for those struggling with opioid addiction, and will continue that practice as we welcome patients in our newest facility. No matter what circumstances we face, our staff puts our patient’s safety, well-being and recovery first. ”

For more information on MedMark and our services visit: http://www.MedMark.com.

To inquire about admission or make a referral, contact Kathleen Mahoney, Treatment Center Director, at 330.552.4000.

About BayMark Health Services:

BayMark Health Services provides medication-assisted treatment to 53,000+ patients in recovery from substance use disorder across the United States and Canada. Our outpatient programs deliver medically-supervised treatment, in a variety of modalities and settings, to meet the diverse needs of our patients who struggle with the use of opioids, alcohol and other prescription and illicit substances.

The BayMark continuum of patient-focused services includes: highly structured opioid treatment programs utilizing methadone or buprenorphine and outpatient buprenorphine treatment programs, both of which incorporate counseling as part of an individualized treatment plan for opioid use disorder. Additionally, ambulatory withdrawal management services with naltrexone therapy, and inpatient detoxification services are offered for a variety of substance use disorders.

Share article on social media or email:

Understanding the Changes & Leveraging the Opportunity, Upcoming Webinar Hosted by Xtalks


Xtalks Life Science Webinars

By understanding this evolving regulatory landscape, device manufacturers across the globe can better position their products to adapt to these changes in support of their device development programs.

Medical devices play an increasingly critical role in the health and quality of life for millions of people worldwide. While clinical trials for medical devices have many similarities to those for pharmaceuticals, the regulatory evaluation of devices is distinct from that of drugs – and there are critical differences in the way the device trials are designed and executed.

In a live webinar taking place on Monday, May 11, 2020 at 3pm KST (Korea), Premier Research’s Nach Davé, Vice President, Development Strategy, and Marlis Sarkany, Senior Medical Director, draw on their extensive experience in both medical device and clinical product development to share what manufacturers need to know. The pair will explore the latest US and European medical device regulatory pathways, agency expectations and other critical best practices.

To reflect the substantial technological and scientific advances made by the medical device sector and to respond to the need for regulations that would significantly tighten the controls around medical devices, the European Commission published the EU Medical Devices Regulation (MDR) on May 5, 2017.

These regulations seek to set the standard for medical device regulation globally and impact the entire product development cycle, from concept to clinical trial conduct and post-marketing surveillance. Manufacturers will need to conduct more rigorous clinical investigations than ever on both safety and effectiveness to support their claims both in Europe and in the US.

By understanding this evolving regulatory landscape, device manufacturers across the globe can better position their products to adapt to these changes in support of their device development programs. Register for the webinar today for an in-depth look at the changes being proposed and the requirements that will need to be met by device manufacturers willing to do business in Europe and beyond.

For more information or to register for this event, visit Asia-Pacific – Taking Device Clinical Development to the US & Europe: Understanding the Changes & Leveraging the Opportunity.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Boston Medical Center Partners with Digital Health Company Rimidi to Add Post-Partum Remote Monitoring for High-Risk Pregnancies


News Image

“This project to address maternal and infant morbidity and mortality due to hypertensive disorders in pregnancy is a great example of how technology can support more proactive and preventative management of a condition that is a public health crisis across the US.”

Boston Medical Center (BMC) today announced a partnership with Rimidi, a cloud-based software platform that enables a more efficient model of care for patients with chronic conditions, to remotely monitor blood pressure for women experiencing high-risk pregnancies. Healthcare experts in the Department of Obstetrics and Gynecology at BMC, including recent medical school graduates, will be the first to use Rimidi’s platform, which has been integrated into the academic medical center’s electronic health record, Epic.

“Women who have gestational hypertension or preeclampsia are considered ‘high-risk’ during and after pregnancies, and can benefit from close monitoring,” said Christina Yarrington, MD, FACOG, an obstetrics and gynecology physician and director of labor and delivery at Boston Medical Center. “In the midst of the COVID-19 pandemic, adding the capability to remotely monitor blood pressure in these patients is especially pressing, as we are trying to limit their exposure to healthcare settings.”

The team at BMC will use Rimidi’s cardiovascular disease platform view, which combines relevant EHR data, with patient-generated blood pressure data from a cellular-connected blood pressure cuff. This allows physicians to manage better outcomes based on actionable, real-time information. According to Yarrington, who is also an assistant professor of obstetrics and gynecology at Boston University School of Medicine, the remote monitoring program will start with a cohort of approximately 60 patients.

“Adverse cardiovascular outcomes like heart attack and stroke—whether pregnancy-related or not—are one of the most preventable causes of mortality in the United States,” said Lucienne Ide, MD, PhD, founder and chief health innovator at Rimidi. “This project to address maternal and infant morbidity and mortality due to hypertensive disorders in pregnancy is a great example of how technology can support more proactive and preventative management of a condition that is a public health crisis across the US.”

With the risk of COVID-19, healthcare systems are taking extra precautions in treating their patients. The adoption of Rimidi’s platform will not only allow physicians at BMC to cut back on fear of exposure by monitoring their patients remotely, but also add in an extra layer of medical support when patients need it most.

To learn more about Boston Medical Center and the steps it’s taking during COVID-19 to better monitor patients, including its visitor policy, visit http://www.bmc.org. For the latest news and information about Rimidi and its technology, including its COVID-19 triage and monitoring application, visit http://www.rimidi.com.

About Boston Medical Center

Boston Medical Center is a private, not-for-profit, 514-bed, academic medical center that is the primary teaching affiliate of Boston University School of Medicine. It is the largest and busiest provider of trauma and emergency services in New England. Boston Medical Center offers specialized care for complex health problems and is a leading research institution, receiving more than $97 million in sponsored research funding in fiscal year 2018. It is the 15th largest funding recipient in the U.S. from the National Institutes of Health among independent hospitals. In 1997, BMC founded Boston Medical Center Health Plan, Inc., now one of the top ranked Medicaid MCOs in the country, as a non-profit managed care organization. Boston Medical Center and Boston University School of Medicine are partners in Boston HealthNet – 14 community health centers focused on providing exceptional health care to residents of Boston. For more information, please visit http://www.bmc.org.

About Rimidi

Rimidi is a cloud-based software platform that enables personalized management of health conditions across populations. Created by doctors, Rimidi avoids the disconnect in connected care by combining patient-generated health data with clinical data from the EHR to drive patient-specific clinical insights and actions. The net effect is a better health system with optimized clinical workflows that enable better decisions, better relationships, better outcomes and ultimately a better healthcare system. For more information, visit rimidi.com and follow us on Facebook, Twitter and LinkedIn.

Media Contacts:

Cortney Williams

ARPR, on behalf of Rimidi

(855) 300-8209

cortney@arpr.com

Jazmin Holdway

Communications Associate, Boston Medical Center

(617) 638.6838

Jazmin.Holdway@bmc.org

Share article on social media or email:



Cisive Executive Shannon Shoemaker Recognized in CEO Today’s Business Women of the Year Awards


Cisive Executive Shannon Shoemaker Recognized in CEO Today’s Business Women of the Year Awards

I am honored to be part of an organization like Cisive that values diversity and inclusion in leadership. I am grateful to have a seat at the leadership table where I can make a difference throughout my work each day.

Cisive, a global provider of compliance-driven human capital management and risk management solutions, today announced the company’s Vice President of Solutions, Marketing and Partnerships Shannon Shoemaker was recognized in CEO Today magazine’s “Business Women of the Year” 2020 special issue. CEO Today acknowledges women who are the driving force behind their business while driving equality in their sector and beyond.

Shannon Shoemaker has managed Cisive’s Solutions, Marketing and Partnerships as Vice President since 2017 and brings over a decade of experience in the background screening industry. Due to Shoemaker’s efforts, Cisive is widely recognized across the globe. In 2017, she was recognized by Columbus Business First as one of the Top 15 People to Know in HR. Currently, she works closely with the Cisive family of companies to maximize each business unit’s marketing opportunities in alignment with the company’s mission.

“Shannon’s recognition as ‘Business Woman of the Year’ in CEO Today is well-deserved,” said James Owens, President and CEO at Cisive. “In less than 18 months, her leadership and vision have established the Cisive brand as the premier provider in the background screening industry. She believes in the Cisive brand’s promise of high quality and has dedicated the past few years in communicating our commitment to excellence in every aspect of our brand experience.”

“It is an honor to be recognized by CEO Today in their annual list of business women,” said Shannon Shoemaker, VP, Brand, Marketing and Partnerships at Cisive. “I am honored to be part of an organization like Cisive that values diversity and inclusion in leadership. I am grateful to have a seat at the leadership table where I can make a difference throughout my work each day.”

In addition to Shoemaker’s recognition in CEO Today’s Business Women of the Year 2020 special issue, Cisive has previously been honored as Company of the Year by CIO Review and as CIO Bulletin’s 30 Admired Companies to Watch in 2020. For more information about Cisive’s suite of solutions, visit http://www.Cisive.com.

About Cisive

Cisive is a global leader in compliance-driven human capital and risk management solutions, providing onboarding and pre-employment background screening solutions to address the complex challenges and needs of large enterprises with dedicated, in-country account management teams committed to customer satisfaction. Cisive is accredited by the Professional Background Screeners Association (PBSA) and was named for the third consecutive year by HRO Today to the 2019 Baker’s Dozen Customer Satisfaction rankings of Top Pre-Employment Screening Providers, in addition to being named Company of the Year by CIO Review. The company and its brands serve clients in financial services, transportation, telecom/media, healthcare, utilities and the home services end-markets, among others. For additional information, please visit http://www.cisive.com.

Share article on social media or email:

What’s That? Spotting Skin Cancer Early Can Save Your Life


“We bring an unmatched level of services to all of our patients and are confident in our approach to treat skin cancer most effectively and efficiently,” says Dr. Foster.

Summer: it’s a recipe for spending more time outdoors. Depending on your activities, all that extra time in the sun is sure to leave you with harmful exposure to ultraviolet (UV) rays if you aren’t using proper sun protection. Did you know more than five million new cases of skin cancer are diagnosed each year? And of those, roughly 85 percent of melanoma cases are associated with exposure to UV radiation from the sun.

Skin cancer is the most common form of cancer in the United States. Every year, skin cancer diagnoses outnumber new cases of many other types of cancers such as breast, colon, lung, and prostate.

“Anyone can get skin cancer. Regardless of skin color or background,” says Medical Director of Florida Dermatology and Skin Cancer Centers, Dr. K. Wade Foster. “Fortunately, skin cancer is one of the most preventable forms of cancer and we can lessen our chances by taking a few important measures.”

So, what can we do to help protect ourselves from a diagnosis?

Check yourself: Florida Dermatology and Skin Cancer Centers recommends that you regularly perform a self-exam by checking yourself in the mirror and looking for any new, unusual or changing areas, and reporting those to your dermatologist right away. An annual skin exam can also help identify suspicious growths, moles, and other dermatological changes. Areas of the skin that are exposed to the sun are more prone to develop moles or certain growths, and because of this, it’s very important to have an experienced dermatologist or licensed medical professional conduct a yearly body analysis to check all areas of your body, including your scalp, neck, and back.

What should you look for?

Florida Dermatology and Skin Cancer Centers (FLDSCC), along with The American Academy of Dermatology recommends conducting annual skin exams to look for the ABCDE’s of skin cancer. A is for Asymmetry: One half of the mole looks different from the other half. B is for Border: The mole has an irregular or poorly defined border. C is for Color: The mole’s color varies from one area to the next, and may include shades of tan, brown or black, or areas of white, red, or blue. D is for Diameter: May be greater than six millimeters, or about the size of a pencil eraser, and can be smaller when diagnosed. E is for Evolving: The mole or lesion is changing in size, shape, or color over time.

Wear sunscreen: Liberally apply sunscreen to all exposed areas of your skin when going outdoors. It’s important to read the label of your sunscreen to make certain it is water-resistant and broad-spectrum with an SPF of 30 or higher. If you are sweating or swimming, you’ll need to reapply every two hours.

Cover up: Sunscreen is only one part of protecting yourself from the sun’s powerful UV rays. In addition to using it, you should wear protective clothing to guarantee extra coverage. Fortunately, lots of companies make long-sleeved and lightweight shirts, pants, hats and sunglasses with UV protection built in. Make use of these especially when around reflective surfaces like the sand, water, and snow. And when you can, during the hours of 10 a.m. and 2 p.m., try to stay under shaded areas since the sun’s UV rays are strongest during that time frame.

Avoid tanning beds: Researchers estimate that indoor tanning may cause upwards of 400,000 cases of skin cancer in the United States each year. Luckily there are alternatives to achieving a sun-kissed glow without UV rays with the use of sunless tanning lotions and spray tanning.

Are you in the know?

  • More than two people die of skin cancer every hour.
  • If you’ve had more than five sunburns, your risk of melanoma has doubled.
  • Melanoma is the second most common form of cancer in females ages 15-29 and is increasing faster in females in this age group than in males of the same age group.
  • It is estimated that melanoma will affect 1 in 27 men and 1 in 40 women in their lifetime.
  • The five-year survival rate for people whose melanoma is detected and treated is 99 percent.

Florida Dermatology and Skin Cancer Centers provides a full spectrum of dermatology and skin care services, and its team of physicians, ARNPs, and PAs are experts in diagnosing and treating skin cancers with the latest technological options. Dr. K. Wade Foster is fellowship-trained in Mohs surgery, the most effective technique for most types of skin cancers, with minimal scarring or risk.

“We bring an unmatched level of services to all of our patients and are confident in our approach to treat skin cancer most effectively and efficiently,” says Dr. Foster. “Fortunately, skin cancer treatment, specifically melanoma, has a very favorable outcome since if it is detected early, it’s almost always treatable.”

For more information about services that Florida Dermatology and Skin Cancer Centers provides, or to make an appointment for a skin exam, visit http://www.fldscc.com or contact us at 863.293.2147.

About Florida Dermatology and Skin Cancer Centers

Florida Dermatology and Skin Cancer Centers, based in Winter Haven, Florida, treats all types of skin and scalp conditions. Medical director K. Wade Foster, MD, PhD, is Fellowship-trained in Mohs surgery, which is the most effective technique for most skin cancers, with minimal scarring or risk. Several convenient locations serve patients throughout Florida. Complete office listings are available online.

For more information about Florida Dermatology and Skin Cancer Centers, visit http://www.fldscc.com or contact Cora Ligon at 863.838.5475. Follow our momentum on Facebook, Instagram, Twitter, and the Florida Dermatology and Skin Cancer Centers blog.

Share article on social media or email:

Top Organizations Share Interactive Resources from AllenComm and Columbia University Department of Psychiatry for Coping with COVID-19


As a service to the community, AllenComm and the Columbia University Department of Psychiatry released two online guides that teach coping skills for getting through the COVID-19 outbreak. COVID-19: Tips for Facing the Lockdown and COVID-19: 5 Tips to Face Your Anxiety have now been distributed by recognizable companies such as Change Healthcare, Chick-Fil-A, and several others.

The organizations that have shared these resources have a strong commitment to the morale of their teams and communities. Their leadership has prompted them to ensure their employees have the resources they need to weather this difficult time.

“I went through [the guide] and was pleased to see it was echoing a lot of what we’ve been sharing with our teams as well,” said one executive. “I will definitely forward it, so others are aware.”

These guides address common frustrations and the anxiety caused by the Coronavirus outbreak. Laid out in easy-to-navigate modules, the guides cover helpful topics such as evaluating helpful vs. harmful thoughts, regulating your mood, changing the stories you tell yourself to ease anxiety, using mindfulness to accept what can’t be changed, finding ways to treat yourself and keep your mind and body active, harnessing the power of changing up your routine to alter your perspective, and finding ways to preserve or strengthen your relationships.

“There are simple, tried and true techniques that psychologists have developed that we can all use to get us through this difficult time,” says Dr. Barbara Stanley, writer of COVID-10: Tips for Facing the Lockdown.

These resources can be accessed by anyone with an internet connection on their mobile device or computer. These guides can also be hosted on corporate, educational, and governmental learning management systems free of charge. Contact AllenComm for more information.

“We are committed to sharing these effective coping skills with our clients and partners,” said Ron Zamir, AllenComm CEO. “While our country focuses on the medical care of so many Americans, we shouldn’t forget that our mental health is under assault. During these times of crisis, we are honored to have developed a resource that is quickly becoming so valuable to businesses and communities.”

About AllenComm

For over 35 years, AllenComm has partnered with Fortune 100 companies to create and scale unique, innovative learning solutions. Extensive instructional design experience, innovative learning technologies, and agency-level creative teams enable AllenComm to stand out in the learning landscape. Considered one of the top ten firms of its kind in the country, AllenComm wins over 40 awards year after year for their tailored learning solutions. With internal workforce and experience, AllenComm is uniquely positioned in the learning space to meet multiple needs from small to very large change management projects. Partnering with AllenComm to supplement and support human capital management needs has helped customers reduce expenses, shorten onboarding periods, and raise the impact of sales and compliance efforts.

For more information, visit allencomm.com.

About Columbia University Department of Psychiatry

The Columbia University Department of Psychiatry is one of the largest in the country in terms of faculty size as well as state, federal, and foundation research support. They are currently among the top-ranked in the nation for Psychiatry in the US News & World Report Best Hospital rankings, as well as in psychiatric research funding from the National Institutes of Health. They have extraordinary clinical, educational, and research resources. Their faculty includes over 400 psychiatrists, psychologists, social workers, nurses, and neurobehavioral scientists. Clinical facilities and laboratories of the Psychiatry Department are located in a large number of institutions and healthcare systems. These include New York-Presbyterian Hospital, Columbia University Irving Medical Center, the New York State Psychiatric Institute, the New York State Office of Mental Health, and the Washington Heights Community Mental Health Center. The Department of Psychiatry also houses the Center for Neurobiology and Behavior, the Mind/Brain Institute, a Howard Hughes Research Institute, and the Stanley Center for Applied Neuroscience of Bipolar Disorders.

Share article on social media or email:

Disinfection of personal items is now a practical option as a new, UV-C LED surface disinfection system, from AquiSense Technologies, is launched


“We accelerated our product development pipeline in response to immediate global needs for reliable reuse disinfection products,” said Oliver Lawal, CEO at AquiSense Technologies.

AquiSense Technologies, the world leader in ultraviolet (UV) LED disinfection technology, is happy to announce it has launched the PearlSurface 24G9™, one of the first UV-C LED surface disinfection products designed for health care applications such as reuse of N95 facemask and other PPE. The PearlSurface 24G9 offers advanced benefits specific to LEDs, including mercury-free lamps, instant-on operation and low cost of ownership, while providing high-power density, homogeneous disinfection of target objects.

The PearlSurface 24G9 is a highly effective breakthrough product offering simple operation, integrated timer, low voltage power supply and compact footprint, ideal for point-of-use hospital settings, care homes, ambulances, police/fire departments, factories, food preparation, etc. AquiSense will offer this product under the current US FDA enforcement relief to deal with immediate COVID-19 emergency use and will simultaneously submit a premarket approval application.

“We accelerated our product development pipeline in response to immediate global needs for reliable reuse disinfection products,” said Oliver Lawal, CEO at AquiSense Technologies. “We are fortunate to be able to leverage an existing high-output UV-C LED module from our water treatment products and draw on our experience in rapid hardware design and optical modeling to ensure a high-level disinfection efficacy,” concluded Lawal.

AquiSense Technologies is currently interested in talking to potential partners and distributors for the PearlSurface 24G9. To learn more about the Product or other UV LED technology applications, you can contact AquiSense at: info@aquisense.com

About AquiSense Technologies

AquiSense Technologies is the global leader in UV-C LED systems design and manufacture. They work with leading LED manufacturers to evaluate their devices and then design efficient disinfection products. Using a combination of patented technology and in-depth know-how, AquiSense integrates LED devices into products that solve real world problems in water, air, and surface applications.

Share article on social media or email:

TreCeuticals Physician-Developed Solutions Restore and Regenerate Skin through Simplified Product Regimen


Best friends and founders of BellaTres

We noticed a lot of confusion with most skincare products. The use of active ingredients is key. These ingredients have to be formulated at a high enough level to produce results.

BellaTres is excited to announce TreCeuticals, a line of scientifically-formulated solutions for those wanting improved texture, tone, and elasticity of facial skin. The company was founded by three friends passionate about skincare who decided to create a very specific, easy-to-use system that is also gender neutral.

“We noticed a lot of confusion with most skincare products. The use of active ingredients is key. These ingredients have to be formulated at a high enough level to produce results,” say the founders. The products will be available through a convenient ship-to-home program, starting April 30th, 2020.

The unique skincare system, developed with the guidance of renowned Facial Aesthetic Surgeon Dr. Paul Holden, fills a need in the self-care routine of busy consumers who want safe and effective skin benefits in a streamlined system.

Holden commented, “After listening to my patients for more than a decade, it became clear they desired an easy, effective, and accessible regimen for their skin that gives great results immediately and long term. Our development team at TreCeuticals has now delivered a science-based product that is unique, simple-to-use and shows significant, sustained improvement. People are going to be amazed at the difference in the way they look and feel after the first week of use.”

TreCeuticals offers these nourishing products without the hassle of buying from a dermatology clinic. Since the products are shipped soon after production, consumers receive the product at maximum potency – something that can’t always be guaranteed with off-the-shelf alternatives. There’s an added benefit of efficiency, as well.

The founding partners explained, “Our packaging is carefully measured and labeled so that you get the best, most effective use from each part of our kit.”

Users can feel better about their purchase, knowing that there won’t be excess product or bulky packaging to discard. The entire line is also cruelty-free.

TreCeuticals offers the luxury customers expect in a quality product without the high price or stress of traditional “systems.” Learn more at TreCeuticals SkinCare

Share article on social media or email:

Westwind Integrated Health in Phoenix, AZ, Raises Awareness of PTSD and Its Effects on Whole-Body Health


Westwind Integrated Health Offers Medical and Dental Care in Phoenix, AZ

Westwind Integrated Health Offers Medical and Dental Care in Phoenix, AZ

I was literally scared to death to go to the dentist. Now, I feel like I can smile and talk and not have to cover my mouth and be embarrassed about it.

The experienced dental-medical team at Westwind Integrated Health (WIH) spreads awareness of PTSD and the damaging effects it has on an individual’s mental, physical, and oral health if not properly treated. Patients suffering from PTSD in Phoenix, AZ and Glendale AZ can reduce dental anxiety, or any anxiety related to medical procedures, and experience calming appointments at WIH with IV sedation. WIH encourages patients with PTSD to seek personalized dental-medical care from a compassionate and caring team to improve their whole-body health.

PTSD, or post-traumatic stress disorder, is a disorder that develops early on or even years after an individual experiences a shocking, scary, dangerous, or other emotionally traumatic events. Anyone can develop PTSD and around 8 percent of individuals will experience PTSD at some point in their lives. Those living with this disorder are generally more likely to experience depression, orofacial problems like teeth grinding and clenching, stress, and chronic pain, and may neglect their physical and oral health. At WIH, the team of integrated dental and medical professionals considers PTSD and the effects it has on whole-body health. Patients with PTSD can find calming and compassionate dental-medical care, including IV sedation to ease dental anxiety, at any of the nine practice locations across Glendale and Phoenix, AZ.

IV sedation is the highest level of conscious sedation and is administered intravenously. Patients are in a very relaxed state during the procedure and often have no memory of their appointment. High fear, high anxiety patients benefit the most from IV sedation, which works to relax their bodies and calm their nervous systems. As a result, the team at WIH can complete more treatments in one visit and in a much more efficient manner. For patients suffering from PTSD, which may cause dental anxiety or trigger a stressful or traumatic memory during their appointments, IV sedation can be an ideal option and help them experience calming and productive dental and medical visits.

“I was literally scared to death to go to the dentist. Now, I feel like I can smile and talk and not have to cover my mouth and be embarrassed about it,” says Penny, a patient at WIH. “The philosophy and mission at Westwind is to satisfy their patients, making them comfortable, explaining in depth what will be done to make sure they have a full understanding, and then walking them through it from beginning to end.”

WIH encourages patients with dental anxiety and those with PTSD to experience the benefits of seeing an integrated team of dental and medical professionals. Taking a compassionate and personalized approach, the WIH team can help patients improve their mental, physical, and oral health with specialized and comfortable treatment. Truly unique in their motivation to provide whole-body care and healing, WIH provides dental and medical healthcare for men, women, and children, offering physicals, vision and hearing screenings, nutritional counseling, comprehensive dental care, and more. Their goal is to help their patients achieve optimal health and a better quality of life.

Individuals who have PTSD or those who suffer from dental anxiety are welcomed to visit WIH for compassionate care and to experience the benefits of IV sedation at these Glendale or Phoenix, AZ practices. To schedule an appointment, visit their website at http://www.westwindintegratedhealth.com or call the main office at 602-457-8024.

About the Practice

Westwind Integrated Health offers dental and medical care from nine locations in the Glendale and Phoenix, AZ areas. As the only private practice in Arizona and one of only a few practices in the country to combine dental and medical care, this team is innovating health care by offering truly comprehensive care with a whole-body approach. Comprised of a multi-disciplinary team of medical doctors and dental clinicians, Westwind Integrated Health offers specialized general dentistry, orthodontics, endodontics, periodontics, oral and maxillofacial surgery. Plus, under the same roof, patients can receive physicals and wellness exams, vision and hearing screenings, vaccinations, nutritional counseling, and minor injury treatment. The family of practices focuses on building genuine patient relationships, comprehensive and state-of-the-art treatment, and improving the long-term health and wellbeing of their patients. To learn more about the multi-specialty team, visit http://www.westwindintegratedhealth.com or call 602-457-8024 to schedule an integrated health consultation.

Share article on social media or email: